Sensory and Connectivity Abnormalities in Autism Spectrum Disorders
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00956579|
Recruitment Status : Recruiting
First Posted : August 11, 2009
Last Update Posted : September 18, 2020
|Condition or disease|
|Autism Spectrum Disorder|
(NOTE: we are currently recruiting individuals between the ages of 14 and 32, either typically developing or with an autism spectrum disorder.)
To study how sensory information is processed by the brain, we primarily use an instrument called MEG (MagnetoEncephaloGraphy), which measures the magnetic brainwaves emitted by our brains. The device does not have any output (i.e., there is no magnetic field); it only measures the waves produced in the brain.
We measure those waves as the participants in the study listen to, view, or otherwise experience simple, non painful, stimuli. For instance, participants may listen to words while sitting in the MEG room, and watching a movie with the sound turned off.
We then combine this information with pictures of the brain from MRI (Magnetic Resonance Imaging - when available), to get an idea about both the anatomy and the function of the brain, so that we can study how the brains of populations with autism spectrum disorders or language disorders may be different from those of typically developing populations.
|Study Type :||Observational|
|Estimated Enrollment :||120 participants|
|Official Title:||MEG/EEG/MRI and Psychophysics Study of Developmental Disorders|
|Actual Study Start Date :||June 2013|
|Estimated Primary Completion Date :||June 2023|
|Estimated Study Completion Date :||June 2023|
Healthy participants ages 14-32 for a neuroimaging study
Individuals with Autism Spectrum Disorder
ASD participants ages 14-32 for a neuroimaging study.
- Saliency of Sensory Stimuli in Developmental Disorders [ Time Frame: up to 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00956579
|Contact: Nicole McGuiggan, Rsch Coord||617-966-9766||TRANSCEND@partners.org|
|United States, Massachusetts|
|Martinos Center or Biomedical Imaging||Recruiting|
|Charlestown, Massachusetts, United States, 02129|
|Principal Investigator:||Tal Kenet, Ph.D||Massachusetts General Hospital|